Figure S5. Frequencies and expression of surface molecules of DC subsets in relation to BrC subtype in patients with SLN negative disease and primary tumors ≤2 cm. Frequencies and expression of surface molecules of DC subsets in relation to BrC subtype in patients with SLN negative disease and primary tumors ≤2 cm (PDF 367 kb
Figure S1. Density of mature DCs in the tumor stroma and malignant cell nest of patients with HGSCs....
Figure S2. Phenotypic analyses of breast duct lymphocytes. a CD161, IL-18Rα, and PLZF expression on ...
Figure S1. Representative immunohistochemistry (IHC) staining images for CD8, CD4, CD20 and CD68. Im...
Figure S2. Frequency and activation state of DC subsets in HLN compared to metastasis negative (SLN-...
Figure S4. TLR7 and TLR8 expression in LN DC subsets and R848-induced activation in tumor negative B...
Table S1. Phenotype of immune cell subsets. An overview of the used phenotypic definitions for each ...
Figure S3. Prognostic effect of LNRcDC CD86 expression levels. Kaplan Meier curves of estimated DFS ...
Figure S1. Flowcytometric gating of cell subsets. Gating strategies for the DC subsets as well as Tr...
Table S5. Differentially expressed genes representing specific immune cell populations across all th...
Figure S1. Representative staining of ILC populations. ILC were gated on lineage negative, CD45+, CD...
A KEGG pathway figure for the enriched pathway B cell receptor signaling pathway in down-regulated g...
Patient and Tumour Characteristics, Responses to Neoadjuvant Chemotherapy (nâ=â33). (DOCX 56Â kb
Figure S6. IRIS-silencing converts TNBC phenotype into luminal phenotype in breast cancer cells. The...
MTS, migration and invasion assays in ductal carcinoma in situ (DCIS) BCL9-KD cells with shRNA 2. A ...
Figure S1. Expression of CD19/CD20, CD79A/B and RAG1/RAG2 in blood cancer cell lines. X axis: 164 bl...
Figure S1. Density of mature DCs in the tumor stroma and malignant cell nest of patients with HGSCs....
Figure S2. Phenotypic analyses of breast duct lymphocytes. a CD161, IL-18Rα, and PLZF expression on ...
Figure S1. Representative immunohistochemistry (IHC) staining images for CD8, CD4, CD20 and CD68. Im...
Figure S2. Frequency and activation state of DC subsets in HLN compared to metastasis negative (SLN-...
Figure S4. TLR7 and TLR8 expression in LN DC subsets and R848-induced activation in tumor negative B...
Table S1. Phenotype of immune cell subsets. An overview of the used phenotypic definitions for each ...
Figure S3. Prognostic effect of LNRcDC CD86 expression levels. Kaplan Meier curves of estimated DFS ...
Figure S1. Flowcytometric gating of cell subsets. Gating strategies for the DC subsets as well as Tr...
Table S5. Differentially expressed genes representing specific immune cell populations across all th...
Figure S1. Representative staining of ILC populations. ILC were gated on lineage negative, CD45+, CD...
A KEGG pathway figure for the enriched pathway B cell receptor signaling pathway in down-regulated g...
Patient and Tumour Characteristics, Responses to Neoadjuvant Chemotherapy (nâ=â33). (DOCX 56Â kb
Figure S6. IRIS-silencing converts TNBC phenotype into luminal phenotype in breast cancer cells. The...
MTS, migration and invasion assays in ductal carcinoma in situ (DCIS) BCL9-KD cells with shRNA 2. A ...
Figure S1. Expression of CD19/CD20, CD79A/B and RAG1/RAG2 in blood cancer cell lines. X axis: 164 bl...
Figure S1. Density of mature DCs in the tumor stroma and malignant cell nest of patients with HGSCs....
Figure S2. Phenotypic analyses of breast duct lymphocytes. a CD161, IL-18Rα, and PLZF expression on ...
Figure S1. Representative immunohistochemistry (IHC) staining images for CD8, CD4, CD20 and CD68. Im...